| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
$120 million industry investment will grow talent and innovation in Virginia's life sciences ecosystem.RICHMOND, Va., Nov. ...
Truist Securities analyst Robyn Karnauskas maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1038 ...
Eli Lilly and Company (NYSE:LLY) today announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing it...
Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New Y...